EGFR-scores characteristics | Cases | % |
---|---|---|
Primary tumors with 2+ or 3+ | 25 | (53.2) |
Lymph node metastases with 2+ or 3+ | 28 | (59.6) |
Unchanged EGFR-scores in lymph node metastases vs. the primary tumor | 31 | (66.0) |
Changed EGFR-scores in lymph node metastases vs. the primary tumor | 16 | (34.0) |
Patients who had 0 or 1+ in primary tumors and changed to 2+ or 3+ in lymph node metastases | 6 | (12.8) |
Patients who had 2+ or 3+ in primary tumors and changed to 0 or 1+ in lymph node metastases | 3 | (6.4) |
Patients who had 0 in primary tumors and changed to 1+, 2+ or 3+ in lymph node metastases | 3 | (6.4) |
Patients who had 1+, 2+ or 3+ in primary tumors and changed to 0 in lymph node metastases | 2 | (4.2) |